Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of Newly-Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia/Lymphoma
University of Washington
University of Washington
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Nebraska
University of Nebraska
Chinese University of Hong Kong
M.D. Anderson Cancer Center
University of Washington
University of California, San Diego
Universität des Saarlandes
M.D. Anderson Cancer Center
Jonsson Comprehensive Cancer Center
M.D. Anderson Cancer Center
University of Maryland, Baltimore
M.D. Anderson Cancer Center
Barbara Ann Karmanos Cancer Institute
University of Washington
Asan Medical Center
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Barbara Ann Karmanos Cancer Institute
St. Jude Children's Research Hospital
Alliance for Clinical Trials in Oncology
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
PETHEMA Foundation
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Fox Chase Cancer Center
M.D. Anderson Cancer Center
Case Comprehensive Cancer Center